Atlas Trials

Bioequivalence Study of Metformin Hydrochloride Extended-Release Tablets USP 750 mg Under Fed Condition

Clinical trial NCT01831674 · COMPLETED

Trial details

NCT number
NCT01831674
Sponsor
IPCA Laboratories Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Fasting
Start date
2012-12-01
Primary completion
2012-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.